PrognoCIS embraces the growing need for e-prescribing capabilities for stakeholders across the care continuum and the many related benefits that improve care quality and reduce costs. So, RxHub is offered as a feature to providers enrolled with Surescripts for e-prescribing.
Within RxHub, providers view the patient’s Prescription Benefit Information (PBI) with details such as eligibility, drug formulary, and lower-cost alternatives. Providers also have access to a patient’s medication history, showing current and past prescriptions, to ensure no conflicting medications are prescribed. With such comprehensive information at hand, providers can :
PrognoCIS EHR is now certified with RxChange and CancelRx by Surescripts, which allow physicians and registered pharmacies to communicate through electronic messages, instead of the less efficient fax or telephone-based communication.
Through PrognoCIS EHR, providers use EPCS to prescribe DEA-class drugs electronically. PrognoCIS enables users to seamlessly and securely transmit e-prescriptions to pharmacies for DEA class I, II, III, IV, and V. The feature enforces two-factor authentication for the prescription of narcotic drugs to ensure that drugs are not prescribed by unauthorized employees such as medical assistants, nurses, or administrative staff. PrognoCIS, as well as Surescripts, keeps track of every prescription for auditing purposes. It then makes those prescriptions available as part of a patient’s medication history, regardless of where and by whom the prescription was given.
e-prescribing is defined as “the computer-based electronic generation, transmission, and filling of a prescription, taking the place of paper and faxed prescriptions.” Intending to improve the quality of patient care, e-prescribing gives healthcare providers the ability to send prescriptions electronically from the point of care directly to the patient’s pharmacy.
Using specialized software systems that can be accessed from both desktops and mobile devices, this approach offers a variety of benefits that include:
Although e-prescribing systems vary in terms of available functionalities, most offer the following standard components.
Providers can typically select from several medication options, including generic alternatives to brand-name drugs. When the patient’s insurance information is available, formulary options may also be included.
Prescriptions can be conveniently created on a provider’s desktop or mobile device and sent directly to the patient’s pharmacy. Most systems offer confirmation of prescription receipt and the ability to manage more than one prescription at a time.
To prevent adverse interactions, e-prescribing software provides an alert if a prescription is considered a potential hazard for some reason. Possible issues include drug-drug interactions, medication duplication, patient allergies, and dosage amounts outside recommended ranges.
When a patient needs a prescription refill, the pharmacy can send the request directly to the provider, who can then approve or deny the refill electronically.
Through various methods—such as the pharmacy’s database, insurance claims for medications, or the electronic medical record—providers can view the patient’s medication history to aid them in prescribing decisions.
One of the most critical roles that e-prescribing plays within healthcare today is in the battle against the opioid epidemic. When providers use electronic prescribing for controlled substances (EPCS), they can better address opioid fraud and abuse and enhance patient safety by:
MMA is a solution from Surescripts that allows providers to analyze prescription usage data and better implement medication management. Providers can:
The Surescripts Insights for Medication Adherence platform helps clinicians to “identify adherence issues and gaps in care with patient-specific medication summaries and receive real-time messages from PBMs and health plans within their EHR workflow at the point of care.”
According to the Agency for Healthcare Research and Quality (AHRQ), adverse drug events (ADEs) account for nearly 700,000 visits to the emergency department and 100,000 hospitalizations annually. The agency reports that nearly five percent of hospitalized patients experience an ADE and say that rates may be even higher in ambulatory care settings.
Although adverse drug events may occur due to various reasons, AHRQ estimates that about half are considered preventable—including medication errors. Historically, such errors have often been linked to some failure within the traditional paper pathway of prescribing, transcribing, and filling/dispensing prescriptions. The paper-prescribing framework is fraught with an array of potential errors due to lack of access to the patient’s complete record, illegible handwriting, inconsistent ordering formats, and lack of alerts for allergies and interactions.
For reasons such as these, improved patient safety is one of the most significant benefits of e-prescribing—which is why the AHRQ recommends the use of computerized provider order entry (CPOE), which incorporates e-prescribing software.
When medications are ordered through e-prescribing software, everyone benefits when it comes to convenience.
E-prescribing reduces healthcare costs in many ways. These include provider access to more cost-effective options when selecting medications, the reduction of medication errors that may require additional care, and the overall optimization of care quality, reducing the need for ongoing intervention.
In fact, one study published in 2014 about the use of e-prescribing in the ambulatory care setting estimated “cost savings due to improved patient outcomes and decreased patient visits…to be between $140 billion and $240 billion over ten years for practices that implement e-prescribing.”
Several federal regulations have significantly impacted the growing momentum of e-prescribing in all patient care settings.
The Health Information Technology for Economic and Clinical Health (HITECH) Act of 2009 proposed “that healthcare professionals throughout the United States have access to EHRs and use them meaningfully according to standards set by the Centers for Medicare and Medicaid Services (CMS).” In that context, the intent of “meaningful use” was to show how technology was being used to improve patient care—and e-prescribing was an important way to do it.
In 2011, CMS established the Medicare and Medicaid EHR Incentive Programs “to encourage Eligible Professionals EPs, eligible hospitals, and CAHs to adopt, implement, upgrade (AIU), and demonstrate meaningful use of certified EHR technology (CEHRT).” As an essential tool within EHR systems, e-prescribing software contributed to the demonstration of meaningful use.
On April 16, 2015, MACRA was signed into law. According to CMS, this bipartisan legislation “created the Quality Payment Program that repeals the Sustainable Growth Rate formula; changes the way that Medicare rewards clinicians for value over volume; streamlines multiple quality programs under the new Merit-Based Incentive Payments System (MIPS); and gives bonus payments for participation in eligible alternative payment models (APMs).”
Although the framework for meaningful use has changed with the implementation of MACRA, it is still an essential component of optimizing patient care. HealthIT.gov notes that within the MACRA model, meaningful use “was transitioned to become one of the four components of the new Merit-Based Incentive Payment System (MIPS), which itself is part of MACRA.” As an integral part of meaningful use, e-prescribing continues to play a critical role in helping providers optimize the quality of patient care and embraces the financial rewards of doing so within this new value-based payment system.
Two types of e-prescribing systems are available to providers—those that stand-alone and those that are integrated into EHR software.
Stand-alone systems cost less and maybe an attractive option for smaller practices. Still, they are more limited in terms of access to patient information and tools that support clinical decision-making.
E-prescribing software integrated into an EHR platform is typically more expensive but offers access tocomprehensive patient records and is supported by various functionalities geared toward optimizing patient care.
Surescripts’ 2017 National Progress Report presents the following data:
In 2017, Surescripts introduced its Real-Time Prescription Benefit and expanded Electronic Prior Authorization solutions.
Surescripts reported that both options were very popular with providers, and rapid adoption is anticipated in the year ahead.
Quality improvement efforts also impact e-prescribing trends. According to a 2018 joint presentation from the Health Information Management Systems Society (HIMSS), the National Council for Prescription Drug Programs (NCPDP), and Surescripts, the following quality improvement efforts are underway:
According to a summary of EHR market trends gleaned by the consulting firm, Kalorama Information, “add-ons” to the EHR are becoming increasingly important. They state, “The benefits of component tools such as computerized provider order entry, e-prescribing, image archiving, and decision support have become clear to end-users, and they may prefer to have these components integrated as part of a suite of applications.”
In our rapidly changing world of healthcare, e-prescribing capabilities are no longerluxuries. Increasingly, they are the essential tools needed to provide the highest quality of patient care, meet regulatory requirements, and optimize efficiencies within your practice.
If you would like to learn more about how our offerings can meet your e-prescribing needs, contact us today for a free demonstration.